Funding for this research was provided by:
CAMS Innovation Fund for Medical Sciences (2018-I2M-1-002)
Key Technologies Research and Development Program (2018YFC2000300)
Received: 2 May 2021
Accepted: 3 February 2022
First Online: 16 March 2022
: The use of clinical samples described in this study are approved by The Institutional Review Board of BGI located in Shenzhen, China (BGI-S022-T1). BGI is the cooperative laboratory of China Marrow Donor Program (CMDP) for HLA typing. The sample was further reviewed by our laboratory, which is responsible for the quality control of the typing data deposited in the bank of CMDP. Written informed consent was obtained from subjects before blood samples were taken.
: Not applicable as the manuscript does not have any individual identifiable patient data.
: The authors declare no conflicts of interest in association with the present study.